Beynon Pharma Private Limited - Due diligence report

A 360° intelligence report on Beynon Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2014-09-04 Vishakapatnam, Andhra Pradesh Active Unlisted Active Compliant
Share
View plans
BP Beynon Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Beynon Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
61/100
Trust Score
Moderate

Beynon Pharma Private Limited is assessed as Moderate with a Trust Score of 61/100. Beynon Pharma Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 25 Jun 2026 from the latest processed filings. Beynon Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2020 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VENKATA SRINIVASA RAO SURA 01234567 Director 01/04/2018 6 yrs Approved
KALAGARA SRIDEVI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: VENKATA SRINIVASA RAO SURA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 45
Growth signals & trust indicators
Asset base grew 38% - capacity expansion.
Operating for 11+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view44/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Dec 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
01 Nov 2017
Director ceased
RAJESWARA RAO HANUMANTHU
30 Aug 2017
Director ceased
VENKATARAMANA DINAVAHI
04 Sep 2014
Incorporated
Registered with Roc Vijayawada
Director appointed
VENKATA SRINIVASA RAO SURA (Managing Director)
Director appointed
KALAGARA SRIDEVI (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2018 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Valmicare Pharmaceuticals Private Limited U01224TG2014PTC092519 Hyderabad, Telangana, India
Revive Healthcare Private Limited U24100HP2006PTC029454 Baddi, Himachal Pradesh, India
Seora Life Sciences Private Limited U36100MH2014PTC259662 Thane, Maharashtra, India
Filix Organics Private Limited U24100TG2013PTC091576 Hyderabad, Telangana, India
Prerna Pharma Industries Private Limited U24230MH1991PTC063919 Mumbai, Maharashtra, India
Amclin U74900PN2015PTC155009 Pune, Maharashtra, India
Santhimadom Pharmaceuticals Pvt Ltd U24231KL1991PTC006263 Ernakulam, Kerala, India
Aditya Medicos Private Limited U24232DL2004PTC129207 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Beynon Pharma Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Beynon Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 55/100, margin trends, ownership structure and peer set for Beynon Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Beynon Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Beynon Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Beynon Pharma Private Limited an active company?

Beynon Pharma Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Beynon Pharma Private Limited financially healthy?

Beynon Pharma Private Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Beynon Pharma Private Limited?

Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Beynon Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Beynon Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Beynon Pharma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Beynon Pharma Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.